<p>Ferroptosis, a major mechanism of non-apoptotic programmed cell death, critically regulates the homeostasis and functionality of peripheral CD4<sup>+</sup> and CD8<sup>+</sup> T cells<sup><CitationRef AdditionalCitationIDS="CR2 CR3 CR4 CR5" CitationID="CR1">1</CitationRef>–<CitationRef CitationID="CR6">6</CitationRef></sup>. Here we demonstrate that in mouse, resistance of T cells to ferroptosis depends critically on the composition of standard rodent diets, and that dietary effects on ferroptosis (DEFs) have a crucial role in regulation of T cell homeostasis and immune responses. DEFs are microbiota-independent and are driven by variations in dietary polyunsaturated and monounsaturated fatty acids (PUFAs and MUFAs) that lead to variations in abundance of lipid species in lymphoid tissues and T cells. Consistently, ferroptosis resistance of human T cells also correlated with plasma lipid profiles across multiple healthy cohorts, exhibiting negative associations with PUFA/MUFA ratios in major lipid classes. DEFs dictate T cell resilience in the absence of the essential lipid peroxide scavenger GPX4 and broadly modulate T cell-dependent humoral immunity and T cell-mediated anti-tumour immunity, including in chimeric antigen receptor T cell therapy. Mechanistically, ACSL4, which preferentially biosynthezises PUFA-containing phospholipids<sup><CitationRef CitationID="CR7">7</CitationRef></sup>, is highly expressed in T cells and underpins DEF-mediated regulation of follicular helper T (T<sub>FH</sub>) cell generation and function. Our findings reveal the physiological significance of lipid metabolism in driving DEFs in immunity and suggest strategies targeting lipid metabolism to enhance vaccine efficacy and T cell-mediated immunotherapy.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Lipid metabolism drives dietary effects on T cell ferroptosis and immunity

  • Naiqi Wang,
  • Zhian Chen,
  • Yin Yao,
  • Chenglong Sun,
  • Wei Wei,
  • Lei Sun,
  • Hao Zhang,
  • Feng Li,
  • Daniel Butcher,
  • Shi-Ran Sun,
  • Jialei Gong,
  • Yingxin Celia Jiang,
  • Yanfei Qi,
  • Jingxuan Huang,
  • Sam Nettelfield,
  • Rui Liu,
  • Xiaoyue Zheng,
  • Chenyu Li,
  • Yang Fu,
  • Haoyuan Geng,
  • Limin Zhao,
  • Hongjian Sun,
  • Yang Yang,
  • Yexin Ge,
  • Mehrdad Pazhouhandeh,
  • Christopher K. Barlow,
  • Katherine Joanna Jeppe,
  • Joseph Yunis,
  • Chen Zhu,
  • Yunbo Wei,
  • Xiaowen Liang,
  • Kim Bridle,
  • David M. Frazer,
  • Siok-Keen Tey,
  • Yuhua Li,
  • Zhaohui Yang,
  • Minglei Shu,
  • Zheng Liu,
  • Darrell Crawford,
  • Di Yu

摘要

Ferroptosis, a major mechanism of non-apoptotic programmed cell death, critically regulates the homeostasis and functionality of peripheral CD4+ and CD8+ T cells16. Here we demonstrate that in mouse, resistance of T cells to ferroptosis depends critically on the composition of standard rodent diets, and that dietary effects on ferroptosis (DEFs) have a crucial role in regulation of T cell homeostasis and immune responses. DEFs are microbiota-independent and are driven by variations in dietary polyunsaturated and monounsaturated fatty acids (PUFAs and MUFAs) that lead to variations in abundance of lipid species in lymphoid tissues and T cells. Consistently, ferroptosis resistance of human T cells also correlated with plasma lipid profiles across multiple healthy cohorts, exhibiting negative associations with PUFA/MUFA ratios in major lipid classes. DEFs dictate T cell resilience in the absence of the essential lipid peroxide scavenger GPX4 and broadly modulate T cell-dependent humoral immunity and T cell-mediated anti-tumour immunity, including in chimeric antigen receptor T cell therapy. Mechanistically, ACSL4, which preferentially biosynthezises PUFA-containing phospholipids7, is highly expressed in T cells and underpins DEF-mediated regulation of follicular helper T (TFH) cell generation and function. Our findings reveal the physiological significance of lipid metabolism in driving DEFs in immunity and suggest strategies targeting lipid metabolism to enhance vaccine efficacy and T cell-mediated immunotherapy.